Hospitals | December 05, 2025
Fortis ropes in 'Yamraj' to launch nationwide helmet safety drive
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Growing patent filings and tier-2 innovators reflect expanding national research base
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
Angelini Ventures has already invested €125 million in 22 startups
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
Subscribe To Our Newsletter & Stay Updated
